XML 85 R74.htm IDEA: XBRL DOCUMENT v3.22.2
ACQUISITION–RELATED (GAINS) CHARGES, PRODUCT DISCONTINUATION AND OTHER - Product Discontinuance (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Restructuring Cost and Reserve [Line Items]        
Severance-related expenses $ 950 $ 0 $ 4,065 $ 0
Total acquisition-related charges 3,222 7 8,630 7
Changes in contingent consideration     (22,351) (988)
Total acquisition-related (gains) charges, product discontinuation and other (18,058) 146 (13,721) 2,019
Nuance Biotech Co. Ltd.        
Restructuring Cost and Reserve [Line Items]        
Nuance Biotech Co. Ltd. agreement dissolution costs 0 0 0 3,000
Flexion        
Restructuring Cost and Reserve [Line Items]        
Changes in contingent consideration 12,523 0 13,317 0
Myoscience Acquisition        
Restructuring Cost and Reserve [Line Items]        
Changes in contingent consideration (8,757) 139 (9,034) (988)
Acquisition Related Fees        
Restructuring Cost and Reserve [Line Items]        
Acquisition-related costs 2,168 7 4,013 7
Other Restructuring        
Restructuring Cost and Reserve [Line Items]        
Acquisition-related costs $ 104 $ 0 $ 552 $ 0